Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Kyoto University School of Medicine, Kyoto, Japan.
Liver Transpl. 2009 Nov;15(11):1420-5. doi: 10.1002/lt.21873.
Adult living donor liver transplantation (LDLT) was developed against the background of a scarcity of deceased donors and has a number of disadvantages leading to in-hospital mortality, such as marginal donors and grafts and recipients suffering from severe conditions. We have thus developed surgical and medical innovations to overcome these disadvantages. The present study analyzes the causes of death and factors affecting in-hospital mortality in adult recipients of LDLT. Between November 1994 and December 2007, 576 consecutive adult patients underwent LDLT at a single medical center. Overall in-hospital mortality was 18.9%. The peak rate was 55.6% in 1996, and the rate gradually decreased thereafter to 4.4% in 2007. The most frequent cause of death was infection (62.5%), which was followed by rejection (15.7%) and nonseptic multiple-organ failure (8.9%). Being intensive care unit-bound before the operation, ABO blood type incompatibility, an absence of postoperative enteral nutrition, and a Model for End-Stage Liver Disease score of 25 or higher were independent risk factors for in-hospital mortality. In ABO-identical and ABO-compatible cases, retransplantation and a positive lymphocyte crossmatch test were additional independent risk factors. In conclusion, even aggressive efforts, preoperative conditions such as being intensive care unit-bound, a high Model for End-Stage Liver Disease score, retransplantation, and a positive lymphocyte crossmatch test are still risk factors. Enteral nutrition could be a promising strategy to improve adult LDLT.
成人活体肝移植(LDLT)是在供体短缺的背景下发展起来的,具有许多导致住院死亡率的缺点,例如边缘供体和移植物以及患有严重疾病的受者。因此,我们已经开发了手术和医疗创新来克服这些缺点。本研究分析了成人 LDLT 受者死亡的原因和影响住院死亡率的因素。1994 年 11 月至 2007 年 12 月,在一家医疗中心连续进行了 576 例成人 LDLT。总体住院死亡率为 18.9%。死亡率最高的年份是 1996 年,为 55.6%,此后逐渐下降,2007 年降至 4.4%。最常见的死亡原因是感染(62.5%),其次是排斥反应(15.7%)和非感染性多器官衰竭(8.9%)。手术前在重症监护病房,ABO 血型不合,术后无肠内营养,终末期肝病模型评分 25 分或更高是住院死亡率的独立危险因素。在 ABO 相同和 ABO 相容的情况下,再次移植和淋巴细胞交叉配型试验阳性是另外的独立危险因素。总之,即使进行了积极的治疗,术前情况如在重症监护病房、终末期肝病模型评分高、再次移植和淋巴细胞交叉配型试验阳性仍然是危险因素。肠内营养可能是提高成人 LDLT 的有前途的策略。